Who owns AEON BIOPHARMA I?
- Ticker: AEON.WS
- CUSIP Number: 00791x118
Tip: Access positions for across all investors
Analyze quarterly positions in Aeon Biopharma I with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aeon Biopharma I stock
Who bought or sold AEON BIOPHARMA I this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Davidson Kempner Capital Management | 367k | $532k | 0% | Mar 2024 |
|
| LMR Partners | 250k | $363k | 0% | Mar 2024 |
|
| Wolverine Asset Management | 189k | $274k | 117% | Mar 2024 |
|
| Tenor Capital Management | 167k | $242M | 0% | Mar 2024 |
|
| Aristeia Capital | 164k | $251k | -54% | Mar 2024 |
|
| D. E. Shaw & Co | 154k | $224k | 0% | Mar 2024 |
|
| Millennium Management | 145k | $210k | 0% | Mar 2024 |
|
| Q Global Advisors | 132k | $192k | -1% | Mar 2024 |
|
| Hudson Bay Capital Management | 100k | $145k | 0% | Mar 2024 |
|
| Whitebox Advisors | 92k | $133k | 0% | Mar 2024 |
|
| Calamos Advisors | 83k | $121k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 80k | $115k | 0% | Mar 2024 |
|
| UBS O'Connor | 75k | $114k | 100% | Mar 2024 |
|
| Kim | 63k | $92k | -24% | Mar 2024 |
|
| OZ Management | 50k | $76k | 0% | Mar 2024 |
|
| DuPont Capital Management Corporation | 50k | $73k | 0% | Mar 2024 |
|
| Farallon Capital Management | 50k | $73k | 100% | Mar 2024 |
|
| Jane Street | 41k | $59k | 1% | Mar 2024 |
|
| Walleye Trading Advisors | 40k | $57k | -39% | Mar 2024 |
|
| Moore Capital Management | 33k | $48k | 0% | Mar 2024 |
|
| Polar Securities | 27k | $42k | 0% | Mar 2024 |
|
| Athos Capital | 25k | $295k | 0% | Mar 2024 |
|
| Sandia Investment Management | 20k | $29k | -70% | Mar 2024 |
|
| Marshall Wace | 20k | $32k | -30% | Mar 2024 |
|
| Hrt Financial | 19k | $27k | 0% | Mar 2024 |
|
| Parallax Volatility Advisers | 12k | $18k | -51% | Mar 2024 |
|
| Walleye Trading | 12k | $17k | -56% | Mar 2024 |
|
| Clear Street | 6.2k | $9.0k | -88% | Mar 2024 |
|
| UBS Group | 4.9k | $7.1k | 451% | Mar 2024 |
|
| David W. Seeley | 1.6k | $2.3k | 0% | Mar 2024 |
|
| Robinson Capital Management | 916.00 | $91.966400 | -10% | Dec 2023 |
|
| Bank of America Corporation | 3.00 | $3.999900 | 0% | Mar 2024 |
|
Who sold out of Aeon Biopharma I?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shaolin Capital Management | Sep 2023 | 794k | $119k |
| Cantor Fitzgerald, L. P. | Dec 2023 | 597k | $60k |
| Cowen And Company | Dec 2023 | 232k | $23k |
| Castle Creek Arbitrage | Sep 2023 | 83k | $13k |
| Warberg Asset Management | Dec 2023 | 54k | $5.3k |
| Rivernorth Capital Management | Dec 2023 | 45k | $3.6k |
| Nomura Holdings | Dec 2023 | 30k | $0 |
| EMG Holdings | Sep 2023 | 25k | $3.7k |
| Schonfeld Strategic Advisors | Dec 2023 | 15k | $1.3k |
| Flow Traders US | Dec 2023 | 11k | $1.0k |